Oko-Oboh Gregrey Agbonvihele, Auvinen Anssi, Obaseki Darlington Ewaen, Pitkäniemi Janne
Health Sciences Unit, Faculty of Social Sciences, Tampere University, Arvo Ylpön katu 34, 33520, Tampere, Finland.
Prostate Cancer Research Center, Tampere University, Tampere, Finland.
Cancer Causes Control. 2025 Apr 23. doi: 10.1007/s10552-025-02001-7.
This study sought to describe the methods of detection (MOD), their determinants and association with type of treatments received for breast, cervical and prostate cancers using a population-based cancer registry in Nigeria.
The study analyzed incident breast (n = 205), cervical (n = 147), and prostate (n = 250) cancers from the Edo-Benin Cancer Registry (EBCR) from 2016 to 2018. The MOD was assigned as health check-up detected or clinically detected. Case proportion ratios (CPR) were used to compare MOD across determinant levels. Statistical association between demographic determinants and MOD were assessed using binomial regression.
Among the cancers recorded by the EBCR, 46% of breast (n = 205), 43% of cervical (n = 146), and 50% of prostate (n = 250) cases were identified through health check-ups. MOD was not significantly linked to age or marital status. Health check-ups were less common in those with less than tertiary education [breast, CPR 0.61 (95% CI 0.46-0.80), cervical, CPR 0.73 (95% CI 0.49-1.08), prostate, CPR 0.64 (95% CI 0.50-0.82)]. Significantly, more cancers detected via health check-ups were assigned to palliative care compared to clinical detection (breast: 76% vs. 58%, cervical: 80% vs. 59%, prostate: 83% vs. 64%).
Health check-up campaigns are a key source of new cases in EBCR, but cancers detected through them are more often assigned to palliative care than those detected clinically. The findings suggest that efforts at early detection are not expressed in treatments assignment. Pre-symptomatic individuals should be encouraged to participate in health check-ups and proper treatment made available to improve these programmes.
本研究旨在利用尼日利亚的一个基于人群的癌症登记处,描述乳腺癌、宫颈癌和前列腺癌的检测方法(MOD)、其决定因素以及与所接受治疗类型的关联。
该研究分析了2016年至2018年来自伊多 - 贝宁癌症登记处(EBCR)的乳腺癌(n = 205)、宫颈癌(n = 147)和前列腺癌(n = 250)的发病病例。MOD被指定为通过健康检查检测到或临床检测到。病例比例比(CPR)用于比较不同决定因素水平下的MOD。使用二项式回归评估人口统计学决定因素与MOD之间的统计关联。
在EBCR记录的癌症病例中,46%的乳腺癌(n = 205)、43%的宫颈癌(n = 146)和50%的前列腺癌(n = 250)病例是通过健康检查发现的。MOD与年龄或婚姻状况无显著关联。在受教育程度低于大专的人群中,健康检查不太常见[乳腺癌,CPR 0.61(95%CI 0.46 - 0.80);宫颈癌,CPR 0.73(95%CI 0.49 - 1.08);前列腺癌,CPR 0.64(95%CI 0.50 - 0.82)]。值得注意的是,与临床检测相比(乳腺癌:76%对58%;宫颈癌:80%对59%;前列腺癌:83%对64%),通过健康检查发现的癌症更多地被分配到姑息治疗。
健康检查活动是EBCR新病例的一个关键来源,但通过健康检查发现的癌症比临床检测发现的癌症更常被分配到姑息治疗中。研究结果表明早期检测的努力在治疗分配中未得到体现。应鼓励无症状个体参与健康检查,并提供适当的治疗以改进这些项目。